Last reviewed · How we verify
Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Central Nervous System Tumors
The purpose of this research study is to learn about the safety and feasibility of giving a personalized DNA vaccine to people with central nervous system tumors that have returned or have been resistant to treatment.
Details
| Lead sponsor | Washington University School of Medicine |
|---|---|
| Phase | PHASE1 |
| Status | RECRUITING |
| Enrolment | 7 |
| Start date | Wed Oct 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Fri Feb 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Pediatric Recurrent Central Nervous System Tumors
Interventions
- Personalized neoantigen DNA vaccine
- Papivax Biotech TDS-IM v2.0
- Peripheral blood draw
Countries
United States